尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Zoghbi Huda Y, 董事. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 11 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €554k. History available since 13 September 2021. The latest transaction was disclosed on 10 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Zoghbi Huda Y is Administrateur and a director of Regeneron Pharmaceuticals, INC. (XNAS). She has filed 11 disclosures in total, and within the recent sample held, the transactions cover the period from 2021-09-15 to 2026-08-12, with 0 in purchases and 553792 in sales. The most frequent transaction nature is Levée d'options.